In a statement, Merck said regulatory agencies have continued to conclude HPV vaccines are safe and effective, as have 30 years of research. Clinical trials have included over 70,000 people with ...

Merck’s earnings estimates for 2025-2030 were lowered, with 2030 EPS now forecast to be significantly below 2024 levels. TD Cowen cut its price target on Merck from $121 to $100, citing weaker ...

On TikTok, there are videos where women talk directly to the camera. They promote the "natural remedies" they say cleared their infections and discuss "holistic healing" recommendations.

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

This obviously indicates a demand issue, but Merck insists that growth will resume in the second half of 2025. Gardasil dominates the market for HPV vaccines but still faces competition from GSK ...

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other important news updates investors shouldn’t miss. Investor optimism is still strong despite ...